X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21074) 21074
Newsletter (1840) 1840
Newspaper Article (340) 340
Dissertation (44) 44
Book Chapter (43) 43
Magazine Article (28) 28
Book / eBook (16) 16
Conference Proceeding (14) 14
Publication (7) 7
Trade Publication Article (4) 4
Web Resource (3) 3
Government Document (1) 1
Paper (1) 1
Reference (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14391) 14391
glioblastoma (10653) 10653
glioblastoma multiforme (8387) 8387
oncology (8345) 8345
cancer (7337) 7337
animals (5709) 5709
glioblastoma - drug therapy (5403) 5403
brain neoplasms - drug therapy (5026) 5026
cell line, tumor (5001) 5001
female (4994) 4994
male (4878) 4878
glioblastoma - pathology (4292) 4292
tumors (4273) 4273
brain tumors (4089) 4089
brain neoplasms - pathology (4086) 4086
chemotherapy (3985) 3985
glioma (3969) 3969
temozolomide (3736) 3736
research (3650) 3650
gliomas (3628) 3628
apoptosis (3572) 3572
middle aged (3487) 3487
mice (3312) 3312
clinical neurology (3276) 3276
adult (3184) 3184
care and treatment (3047) 3047
brain cancer (3044) 3044
expression (2790) 2790
glioblastoma - metabolism (2778) 2778
radiotherapy (2776) 2776
aged (2765) 2765
brain neoplasms - metabolism (2363) 2363
survival (2217) 2217
analysis (2176) 2176
glioblastoma - genetics (2145) 2145
cell biology (2073) 2073
dacarbazine - analogs & derivatives (2001) 2001
prognosis (1980) 1980
glioma - drug therapy (1935) 1935
health aspects (1935) 1935
medicine & public health (1912) 1912
brain neoplasms - genetics (1902) 1902
malignant glioma (1902) 1902
brain (1883) 1883
proteins (1878) 1878
glioma - pathology (1863) 1863
gene expression (1861) 1861
glioblastoma-multiforme (1824) 1824
surgery (1744) 1744
stem cells (1719) 1719
therapy (1677) 1677
brain neoplasms - therapy (1671) 1671
treatment outcome (1642) 1642
growth (1607) 1607
cancer therapies (1553) 1553
apoptosis - drug effects (1550) 1550
neurology (1528) 1528
angiogenesis (1516) 1516
biochemistry & molecular biology (1512) 1512
pharmacology & pharmacy (1511) 1511
cell proliferation - drug effects (1506) 1506
mice, nude (1499) 1499
antineoplastic agents - pharmacology (1476) 1476
genetic aspects (1473) 1473
glioblastoma - therapy (1468) 1468
neurosciences (1454) 1454
medical prognosis (1445) 1445
antineoplastic agents - therapeutic use (1424) 1424
cell proliferation (1373) 1373
drug therapy (1360) 1360
signal transduction (1359) 1359
in-vitro (1332) 1332
drugs (1309) 1309
cells (1303) 1303
glioblastoma - radiotherapy (1292) 1292
development and progression (1282) 1282
brain neoplasms - radiotherapy (1279) 1279
xenograft model antitumor assays (1264) 1264
brain-tumors (1259) 1259
combined modality therapy (1257) 1257
kinases (1256) 1256
bevacizumab (1216) 1216
magnetic resonance imaging (1211) 1211
medicine, research & experimental (1199) 1199
radiation therapy (1193) 1193
medicine (1190) 1190
tumor cells, cultured (1169) 1169
brain neoplasms - mortality (1165) 1165
medical research (1165) 1165
clinical trials (1161) 1161
adjuvant temozolomide (1156) 1156
malignant gliomas (1144) 1144
inhibition (1127) 1127
antineoplastic agents (1125) 1125
multidisciplinary sciences (1123) 1123
in-vivo (1118) 1118
immunotherapy (1101) 1101
radiation (1096) 1096
cell cycle (1074) 1074
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (23177) 23177
Japanese (112) 112
French (92) 92
German (71) 71
Russian (27) 27
Chinese (18) 18
Portuguese (15) 15
Spanish (14) 14
Polish (10) 10
Hungarian (9) 9
Danish (6) 6
Dutch (4) 4
Italian (4) 4
Norwegian (3) 3
Czech (2) 2
Swedish (2) 2
Bulgarian (1) 1
Croatian (1) 1
Hebrew (1) 1
Icelandic (1) 1
Korean (1) 1
Persian (1) 1
Romanian (1) 1
Serbian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 09/2012, Volume 7, Issue 9, p. e44603
Background: Glioma, including anaplastic astrocytoma and glioblastoma multiforme (GBM) are among the most commonly diagnosed malignant adult brain tumors. GBM... 
CELLS | GLIOBLASTOMA | PROTECTION | GLUCOSE | MULTIDISCIPLINARY SCIENCES | CONCOMITANT | CANCER-RISK | MALIGNANT GLIOMAS | 2-DEOXY-D-GLUCOSE | CHEMOTHERAPY | TEMOZOLOMIDE | Astrocytoma - radiotherapy | Neoplasm Transplantation | Body Weight | Dacarbazine - therapeutic use | Brain Neoplasms - pathology | Luminescence | Antineoplastic Agents, Alkylating - pharmacology | Male | Glioblastoma - radiotherapy | Glioma - radiotherapy | Astrocytoma - pathology | Glioma - pathology | Astrocytoma - drug therapy | Dacarbazine - analogs & derivatives | Brain Neoplasms - radiotherapy | Insulin-Like Growth Factor I - therapeutic use | Fasting | Mice, Inbred C57BL | Rats | Brain Neoplasms - drug therapy | Animals | Glioblastoma - pathology | Cell Line, Tumor | Mice | Blood Glucose - metabolism | Glioblastoma - drug therapy | Glioma - drug therapy | Chemotherapy | Gliomas | Blood sugar | Development and progression | Temozolomide | Radiotherapy | Health aspects | Cancer | Short term | Brain | Cell culture | Animal models | Insulin-like growth factor I | Brain tumors | Brain cancer | Glioblastoma | Insulin-like growth factors | Cancer therapies | Mimicry | Angiogenesis | Metabolites | Surgery | Glioma cells | DNA methylation | Bone marrow | Physiology | Drug dosages | Astrocytoma | Deoxyribonucleic acid--DNA | Sensitizing | Starvation | Cell survival | Tumor cells | Invasiveness | Melanoma | Radio | Radiation therapy | Metabolism | Insulin | Glioblastoma multiforme | Survival | Gerontology | Blood circulation | In vivo methods and tests | Tumors | Deoxyribonucleic acid | DNA
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2005, Volume 352, Issue 10, pp. 987 - 996
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 1460-2105, 2015, Volume 107, Issue 3
Journal Article
Biomaterials, ISSN 0142-9612, 2012, Volume 34, Issue 1, pp. 196 - 208
...’ drug delivery system for enhanced targeted glioblastoma therapy. Important parameters such as particle size distribution, zeta potential and surface content... 
Advanced Basic Science | Dentistry | Anti-glioblastoma | Chemotherapy | Nanoparticle | Drug delivery system | Activatable cell penetrating peptide | Paclitaxel | FUNCTIONALIZED NANOPARTICLES | MATERIALS SCIENCE, BIOMATERIALS | DRUG-DELIVERY | PLA NANOPARTICLES | ENGINEERING, BIOMEDICAL | GLIOMA | CELL-PENETRATING PEPTIDES | POLY(ETHYLENE GLYCOL)-CO-POLY(EPSILON-CAPROLACTONE) NANOPARTICLES | BRAIN-TUMORS | IN-VIVO | BLOOD-BRAIN | Coumarins - metabolism | Molecular Weight | Paclitaxel - pharmacology | Nanoparticles - chemistry | Ethylene Oxide - chemistry | Spheroids, Cellular - pathology | Male | Paclitaxel - pharmacokinetics | Matrix Metalloproteinase 9 - metabolism | Spheroids, Cellular - drug effects | Lactones - chemistry | Tissue Distribution - drug effects | Protamines - chemistry | Matrix Metalloproteinase 2 - metabolism | Endocytosis - drug effects | Spheroids, Cellular - metabolism | Kaplan-Meier Estimate | Nanoparticles - ultrastructure | Rats | Paclitaxel - therapeutic use | Rats, Sprague-Dawley | Diagnostic Imaging | Animals | Glioblastoma - pathology | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | Glioblastoma - drug therapy | Drug Delivery Systems - methods | Microscopy, Fluorescence | Drugs | Nanoparticles | Drug delivery systems | Biological products | Smart drugs and nutrients | Glioblastoma multiforme | Vehicles
Journal Article
Cancer cell, ISSN 1535-6108, 2016, Volume 29, Issue 4, pp. 563 - 573
Intratumoral heterogeneity of signaling networks may contribute to targeted cancer therapy resistance, including in the highly lethal brain cancer glioblastoma (GBM... 
CANCER-CELLS | PATHWAYS | APOPTOSIS | IMAGING-SYSTEM | EVEROLIMUS | ONCOLOGY | MTOR KINASE INHIBITORS | ACQUIRED-RESISTANCE | SENSITIVITY | TUMOR-CELLS | DISCOVERY | CELL BIOLOGY | Adaptation, Physiological | Humans | Pyrazines - administration & dosage | Brain Neoplasms - pathology | Drug Resistance, Neoplasm | Neoplasm Proteins - antagonists & inhibitors | Gene Expression Profiling | Mechanistic Target of Rapamycin Complex 2 | Molecular Targeted Therapy | Neoplasm Proteins - metabolism | Phosphoproteins - metabolism | Brain Neoplasms - metabolism | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Mechanistic Target of Rapamycin Complex 1 | Multiprotein Complexes - antagonists & inhibitors | Nitriles - administration & dosage | TOR Serine-Threonine Kinases - antagonists & inhibitors | Single-Cell Analysis - methods | Glioblastoma - metabolism | TOR Serine-Threonine Kinases - physiology | Proteomics - methods | Neoplasm Proteins - genetics | Receptor, Epidermal Growth Factor - physiology | Selection, Genetic | Brain Neoplasms - drug therapy | Multiprotein Complexes - physiology | Drug Synergism | Xenograft Model Antitumor Assays | Genes, erbB-1 | Animals | Dasatinib - administration & dosage | Signal Transduction - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Models, Biological | Protein Kinase Inhibitors - therapeutic use | Butadienes - administration & dosage | Glioblastoma - pathology | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Mice | Mutation | Glioblastoma - drug therapy | Medical colleges | Analysis | Brain tumors | Research institutes | Drug therapy, Combination | Drug resistance | Health aspects | Glioblastoma multiforme
Journal Article